retatrutide weight loss clinical trials retatrutide Phase 3: TRIUMPH Program Results 2026 People Are Injecting Themselves With

Zepbound, Wegovy, Oral Wegovy, and Foundayo are all FDA-approved, and many insurance plans cover them when prescribed for weight management or a related condition such as obesity, high blood pressure, or sleep apnea

By leveraging AI in these ways, the development of GLP-1 receptor agonists in Australia is becoming more efficient, personalized, and effective, contributing to better management of diabetes and obesity

While the long half-life of semaglutide theoretically supports less frequent dosing, clinical data supports either daily oral or weekly injectable schedules

Avoid alcohol and very sugary drinks, which can make dehydration worse

Women who took both also showed improvements in their metabolic health